Cargando…

Glucagon receptor signaling at white adipose tissue does not regulate lipolysis

Although the physiological role of glucagon receptor signaling in the liver is well defined, the impact of glucagon receptor (Gcgr) signaling on white adipose tissue (WAT) continues to be debated. Although numerous studies propose that glucagon stimulates WAT lipolysis, we lack evidence that physiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasileva, Anastasiia, Marx, Tyler, Beaudry, Jacqueline L., Stern, Jennifer H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Physiological Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576180/
https://www.ncbi.nlm.nih.gov/pubmed/36002172
http://dx.doi.org/10.1152/ajpendo.00078.2022
_version_ 1784811472952492032
author Vasileva, Anastasiia
Marx, Tyler
Beaudry, Jacqueline L.
Stern, Jennifer H.
author_facet Vasileva, Anastasiia
Marx, Tyler
Beaudry, Jacqueline L.
Stern, Jennifer H.
author_sort Vasileva, Anastasiia
collection PubMed
description Although the physiological role of glucagon receptor signaling in the liver is well defined, the impact of glucagon receptor (Gcgr) signaling on white adipose tissue (WAT) continues to be debated. Although numerous studies propose that glucagon stimulates WAT lipolysis, we lack evidence that physiological concentrations of glucagon regulate WAT lipolysis. In turn, we performed studies in both wild-type and WAT Gcgr knockout mice to determine if glucagon regulates lipolysis at WAT in the mouse. We assessed the effects of fasting and acute exogenous glucagon administration in wild-type C57BL/6J and Gcgr(Adipocyte+/+) versus Gcgr(Adipocyte−/−) mice. Using an ex vivo lipolysis protocol, we further examined the direct effects of glucagon on physiologically (fasted) and pharmacologically stimulated lipolysis. We found that adipocyte Gcgr expression did not affect fasting-induced lipolysis or hepatic lipid accumulation in lean or diet-induced obese (DIO) mice. Acute glucagon administration did not affect serum nonesterified fatty acids (NEFA), leptin, or adiponectin concentration, but did increase serum glucose and FGF21, regardless of genotype. Glucagon did not affect ex vivo lipolysis in explants from either Gcgr(Adipocyte+/+) or Gcgr(Adipocyte−/−) mice. Gcgr expression did not affect fasting-induced or isoproterenol-stimulated lipolysis from WAT explants. Moreover, glucagon receptor signaling at WAT did not affect body weight or glucose homeostasis in lean or DIO mice. Our studies have established that physiological levels of glucagon do not regulate WAT lipolysis, either directly or indirectly. Given that glucagon receptor agonism can improve dyslipidemia and decrease hepatic lipid accumulation, it is critical to understand the tissue-specific effects of glucagon receptor action. Unlike the crucial role of hepatic glucagon receptor signaling in maintaining glucose and lipid homeostasis, we observed no metabolic consequence of WAT glucagon receptor deletion. NEW & NOTEWORTHY It has been postulated that glucagon stimulates lipolysis and fatty acid release from white adipose tissue. We observed no metabolic effects of eliminating or activating glucagon receptor signaling at white adipose tissue.
format Online
Article
Text
id pubmed-9576180
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Physiological Society
record_format MEDLINE/PubMed
spelling pubmed-95761802022-10-24 Glucagon receptor signaling at white adipose tissue does not regulate lipolysis Vasileva, Anastasiia Marx, Tyler Beaudry, Jacqueline L. Stern, Jennifer H. Am J Physiol Endocrinol Metab Research Article Although the physiological role of glucagon receptor signaling in the liver is well defined, the impact of glucagon receptor (Gcgr) signaling on white adipose tissue (WAT) continues to be debated. Although numerous studies propose that glucagon stimulates WAT lipolysis, we lack evidence that physiological concentrations of glucagon regulate WAT lipolysis. In turn, we performed studies in both wild-type and WAT Gcgr knockout mice to determine if glucagon regulates lipolysis at WAT in the mouse. We assessed the effects of fasting and acute exogenous glucagon administration in wild-type C57BL/6J and Gcgr(Adipocyte+/+) versus Gcgr(Adipocyte−/−) mice. Using an ex vivo lipolysis protocol, we further examined the direct effects of glucagon on physiologically (fasted) and pharmacologically stimulated lipolysis. We found that adipocyte Gcgr expression did not affect fasting-induced lipolysis or hepatic lipid accumulation in lean or diet-induced obese (DIO) mice. Acute glucagon administration did not affect serum nonesterified fatty acids (NEFA), leptin, or adiponectin concentration, but did increase serum glucose and FGF21, regardless of genotype. Glucagon did not affect ex vivo lipolysis in explants from either Gcgr(Adipocyte+/+) or Gcgr(Adipocyte−/−) mice. Gcgr expression did not affect fasting-induced or isoproterenol-stimulated lipolysis from WAT explants. Moreover, glucagon receptor signaling at WAT did not affect body weight or glucose homeostasis in lean or DIO mice. Our studies have established that physiological levels of glucagon do not regulate WAT lipolysis, either directly or indirectly. Given that glucagon receptor agonism can improve dyslipidemia and decrease hepatic lipid accumulation, it is critical to understand the tissue-specific effects of glucagon receptor action. Unlike the crucial role of hepatic glucagon receptor signaling in maintaining glucose and lipid homeostasis, we observed no metabolic consequence of WAT glucagon receptor deletion. NEW & NOTEWORTHY It has been postulated that glucagon stimulates lipolysis and fatty acid release from white adipose tissue. We observed no metabolic effects of eliminating or activating glucagon receptor signaling at white adipose tissue. American Physiological Society 2022-10-01 2022-08-24 /pmc/articles/PMC9576180/ /pubmed/36002172 http://dx.doi.org/10.1152/ajpendo.00078.2022 Text en Copyright © 2022 The Authors. https://creativecommons.org/licenses/by/4.0/Licensed under Creative Commons Attribution CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/) . Published by the American Physiological Society.
spellingShingle Research Article
Vasileva, Anastasiia
Marx, Tyler
Beaudry, Jacqueline L.
Stern, Jennifer H.
Glucagon receptor signaling at white adipose tissue does not regulate lipolysis
title Glucagon receptor signaling at white adipose tissue does not regulate lipolysis
title_full Glucagon receptor signaling at white adipose tissue does not regulate lipolysis
title_fullStr Glucagon receptor signaling at white adipose tissue does not regulate lipolysis
title_full_unstemmed Glucagon receptor signaling at white adipose tissue does not regulate lipolysis
title_short Glucagon receptor signaling at white adipose tissue does not regulate lipolysis
title_sort glucagon receptor signaling at white adipose tissue does not regulate lipolysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576180/
https://www.ncbi.nlm.nih.gov/pubmed/36002172
http://dx.doi.org/10.1152/ajpendo.00078.2022
work_keys_str_mv AT vasilevaanastasiia glucagonreceptorsignalingatwhiteadiposetissuedoesnotregulatelipolysis
AT marxtyler glucagonreceptorsignalingatwhiteadiposetissuedoesnotregulatelipolysis
AT beaudryjacquelinel glucagonreceptorsignalingatwhiteadiposetissuedoesnotregulatelipolysis
AT sternjenniferh glucagonreceptorsignalingatwhiteadiposetissuedoesnotregulatelipolysis